Education
About Us
Working with TipRanks
Follow Us
Mabpharm Limited (HK:2181)
:2181
2181 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.10 - HK$0.94
Previous CloseN/A
Volume6.00K
Average Volume (3M)160.20K
Market Cap
HK$2.06B
Enterprise ValueN/A
Total Cash (Recent Filing)HK$89.34M
Total Debt (Recent Filing)¥293.09M
Price to Earnings (P/E)―
Beta1.33
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding4,124,080,000
10 Day Avg. Volume40,000
30 Day Avg. Volume160,200
Financial Highlights & Ratios
PEG Ratio-0.23
Price to Book (P/B)13.98
Price to Sales (P/S)0.00
P/FCF Ratio-21.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mabpharm Limited News
PremiumCompany Announcements
Mabpharm Limited Schedules Board Meeting for Annual Results Review
PremiumCompany Announcements
Mabpharm Gains Approval in Pakistan for Key Drug
PremiumCompany Announcements
Mabpharm Gains Indonesian Approval for Key DrugPremiumCompany Announcements
Mabpharm Ends Lease Early for Strategic Growth
PremiumCompany Announcements
Mabpharm Limited Reports Mixed Mid-Year Results
PremiumCompany Announcements
Mabpharm Limited Announces Upcoming Board Meeting2181 FAQ
What was Mabpharm Limited’s price range in the past 12 months?
Mabpharm Limited lowest stock price was HK$0.10 and its highest was HK$0.94 in the past 12 months.
What is Mabpharm Limited’s market cap?
Mabpharm Limited’s market cap is HK$2.06B.
When is Mabpharm Limited’s upcoming earnings report date?
Mabpharm Limited’s upcoming earnings report date is Aug 27, 2025 which is in 84 days.
How were Mabpharm Limited’s earnings last quarter?
Mabpharm Limited released its earnings results on Mar 26, 2025. The company reported -HK$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.008.
Is Mabpharm Limited overvalued?
According to Wall Street analysts Mabpharm Limited’s price is currently Overvalued.
Does Mabpharm Limited pay dividends?
Mabpharm Limited does not currently pay dividends.
What is Mabpharm Limited’s EPS estimate?
Mabpharm Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mabpharm Limited have?
Mabpharm Limited has 4,124,080,000 shares outstanding.
What happened to Mabpharm Limited’s price movement after its last earnings report?
Mabpharm Limited reported an EPS of -HK$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.091%.
Which hedge fund is a major shareholder of Mabpharm Limited?
Currently, no hedge funds are holding shares in HK:2181
Mabpharm Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
44.92%
12-Months-Change
Fundamentals
Return on Equity
-86.56%
Trailing 12-Months
Asset Growth
-5.09%
Trailing 12-Months
Company Description
Mabpharm Limited
Mabpharm Limited (2181) is a biopharmaceutical company focused on the research, development, and commercialization of monoclonal antibody drugs. The company operates primarily in the biotechnology sector, specializing in the treatment of autoimmune diseases, cancer, and infectious diseases. Mabpharm Limited is dedicated to providing innovative therapeutic solutions to enhance patient care and improve health outcomes.
Technical Analysis
CanSino Biologics, Inc. Class H
―
Viva Biotech Holdings
―
Genscript Biotech
―
Wuxi Biologics (Cayman)
―
Pop Mart International Group Limited
―